Related Experiment Video
Updated: Jun 18, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor
Fei Liao1, Weiguo Dong, Lifang Fan
1Department of Gastroenterology, Renmin Hospital, and Pathology Department, Wuhan University, 99# Zhi yang Road, 430060, Wuhan, Hubei, People's Republic of China.
Abstract:
Hepatoma-derived growth factor (HDGF) is a novel multifunctional growth factor that elicits pleiotropic effects on biological processes such as lung remodeling and renal development. Recent studies demonstrated that HDGF is related to tumor proliferation, invasion, angiogenesis, and apoptosis. However, the molecular mechanism of HDGF's involvement in apoptosis remains to be clarified. In this study, we first analyze the role of HDGF in colorectal carcinoma (CRC) progression by immunohistochemistry. Then we used small interference RNA (HDGF-siRNA) to block HDGF and assessed its effect on inducing apoptosis of CRC loVo cells. Apoptosis was detected using flow cytometry (FCM), DNA ladder analysis, and Hoechst 33258 staining. In addition, the expression levels of some apoptosis-related proteins were examined by western blot. The result showed that HDGF expression gradually increased in the colorectal carcinogenesis process. Further studies demonstrated that knock-down of HDGF can down-regulate the survivin, activate the mitochondrial pathway, and induce apoptosis in loVo cells. These findings suggest that HDGF is involved in colorectal carcinogenesis process. Further blocking HDGF exhibits potent pro-apoptotic properties in colon cancer cells. Thus, HDGF might be a potential therapeutic target for human colorectal cancer. These findings may have major implications in the treatment of colorectal cancer.
Insights
Hepatoma-derived growth factor (HDGF) promotes colorectal cancer progression. Blocking HDGF induces apoptosis in colon cancer cells, suggesting it as a potential therapeutic target for colorectal cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Hepatoma-derived growth factor (HDGF) is a multifunctional growth factor implicated in tumor proliferation, invasion, angiogenesis, and apoptosis.
- The precise molecular mechanisms of HDGF's role in apoptosis, particularly in colorectal cancer, require further elucidation.
Purpose of the Study:
- To investigate the role of HDGF in colorectal carcinoma (CRC) progression.
- To determine the effect of blocking HDGF on inducing apoptosis in CRC cells.
- To explore HDGF as a potential therapeutic target for colorectal cancer.
Main Methods:
- Immunohistochemistry was used to analyze HDGF expression in CRC.
- Small interference RNA (HDGF-siRNA) was employed to inhibit HDGF expression in loVo cells.
- Apoptosis was assessed via flow cytometry, DNA ladder analysis, and Hoechst 33258 staining.
- Western blot analysis was performed to examine apoptosis-related protein expression.
Main Results:
- HDGF expression was found to increase progressively during colorectal carcinogenesis.
- Knock-down of HDGF led to the down-regulation of survivin and activation of the mitochondrial apoptotic pathway in loVo cells.
- Inhibition of HDGF effectively induced apoptosis in colon cancer cells.
Conclusions:
- HDGF plays a significant role in the colorectal carcinogenesis process.
- Blocking HDGF demonstrates potent pro-apoptotic effects in colon cancer cells.
- HDGF represents a promising therapeutic target for human colorectal cancer, with potential implications for treatment strategies.
More Related Videos
Related Concept Videos
Apoptosis
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway

